Among those not currently using GLP-1 medications, 4% of respondents said they have concrete plans to begin using GLP-1 in the next 12 months, while an additional 13% said they are considering starting the medication
Additional research has also shown that GLP-1 agonists can cause hemiplegic migraines (24)
These symptoms are typically most pronounced during the initial weeks of treatment or following dose increases, as the body adjusts to the medication's effects on gastric emptying and satiety signalling
L-Carnitin-Mangel erkennen und behandeln Ein Mangel an L-Carnitin kann zu erheblichen gesundheitlichen Problemen fhren
Baseline assessment should include current thyroid status with TSH, free T4, and free T3 levels, documentation of Graves disease treatment history and current management, assessment of thyroid eye disease or other complications, cardiovascular evaluation including heart rate and rhythm (as both hyperthyroidism and GLP-1 receptor agonists can affect heart rate), and standard metabolic parameters including HbA1c, lipid profile, and renal function